Published online Nov 26, 2020. doi: 10.4330/wjc.v12.i11.540
Peer-review started: August 25, 2020
First decision: September 21, 2020
Revised: September 22, 2020
Accepted: October 11, 2020
Article in press: October 11, 2020
Published online: November 26, 2020
Processing time: 93 Days and 3.1 Hours
Congenital aortic valve stenosis is the most frequent type of left ventricular outflow tract obstruction in the pediatric population and accounts for more than three-fourths of the left ventricular outflow tract obstruction cases in children. The two most commonly implemented modalities include balloon aortic valvuloplasty (BAV) and surgical aortic valvotomy, which have demonstrated an equivalent incidence of aortic regurgitation (AR), gradient reduction, and survival outcomes.
Another mode of balloon stabilization during BAV includes rapid ventricular pacing, which decreases stroke volume, pulse pressure, and blood pressure without causing cardiac standstill and without the limitations associated with other techniques. Rapid right ventricular pacing (RRVP) was initially reported in 2002 and has since been broadly implemented throughout the world. Rapid left ventricular pacing has also been reported but is less widely implemented. RRVP is commonly utilized during BAV in older children and adults, but there is a scarcity of data regarding neonates and infants.
RRVP is commonly utilized during BAV in older children and adults, but there is a scarcity of data regarding neonates and infants. We aimed to systematically review the literature and assess the safety and efficacy of RRVP-assisted BAV in children.
A systematic review of the MEDLINE, Cochrane Library, and Scopus databases was conducted according to the PRISMA guidelines (end-of-search date: July 8, 2020). The National Heart, Lung, and Blood Institute and Newcastle-Ottawa scales was utilized for quality assessment.
Five studies reporting on 72 patients were included. The studies investigated the use of RRVP-assisted BAV in infants (> 1 mo) and older children, but not in neonates. Ten (13.9%) patients had a history of some type of aortic valve surgical or catheterization procedure. Before BAV, 58 (84.0%), 7 (10.1%), 4 (5.9%) patients had aortic regurgitation (AR) grade 0 (none), 1 (trivial), 2 (mild), respectively. After BAV, 34 (49.3%), 6 (8.7%), 26 (37.7%), 3 (4.3%), patients had AR grade 0, 1, 2, and 3 (moderate), respectively. No patient developed severe AR after RRVP. One (1.4%) developed ventricular fibrillation and was defibrillated successfully. No additional arrhythmias or complications occurred during RRVP.
RRVP is an effective and safe procedure that can help stabilize the balloon during BAV and decrease subsequent AR rates. No reports of severe AR after RRVP-assisted BAV in children have been published to date.
Future studies should explore the role of RRVP-assisted BAV in neonates and infants.